CUR5g
CAS No. 1370032-20-4
CUR5g ( —— )
产品货号. M36540 CAS No. 1370032-20-4
CUR5g 是一种有效的自噬 (autophagy) 抑制剂。CUR5g 通过阻断自噬体-溶酶体融合选择性地抑制癌细胞中的自噬体降解。CUR5g 通过依赖 UVRAG 的机制阻止 STX17 募集到自噬体,导致自噬体无法与溶酶体融合。CUR5g 可提高顺铂 (Cisplatin,HY-17394) 在体外和体内对 A549 细胞的抗癌作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1202 | 有现货 |
|
| 5MG | ¥1841 | 有现货 |
|
| 10MG | ¥2931 | 有现货 |
|
| 25MG | ¥5693 | 有现货 |
|
| 50MG | ¥9071 | 有现货 |
|
| 100MG | ¥13235 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CUR5g
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CUR5g 是一种有效的自噬 (autophagy) 抑制剂。CUR5g 通过阻断自噬体-溶酶体融合选择性地抑制癌细胞中的自噬体降解。CUR5g 通过依赖 UVRAG 的机制阻止 STX17 募集到自噬体,导致自噬体无法与溶酶体融合。CUR5g 可提高顺铂 (Cisplatin,HY-17394) 在体外和体内对 A549 细胞的抗癌作用。
-
产品描述CUR5g is a potent autophagy inhibitor. CUR5g selectively inhibits autophagosome degradation in cancer cells by blocking autophagosome-lysosome fusion. CUR5g blocks the recruitment of STX17 to autophagosomes via a UVRAG-dependent mechanism, resulting in the inability of autophagosomes to fuse with lysosomes. CUR5g improves the anticancer effect of Cisplatin (HY-17394) against A549 cells both in vitro and in vivo.
-
体外实验Cell Autophagy AssayCell Line:A549 cellsConcentration:0, 1, 5, 10, 20, and 40 μM Incubation Time:3, 6, 12, and 24 h Result:Induced extensive cytoplasmic vacuolization, and GFP-LC3B signal shifted from diffuse cytosolic staining to a punctate pattern outlining autophagosomes.Western Blot Analysis Cell Line:A549 cells Concentration:0, 1, 5, 10, 20, and 40 μM Incubation Time:0, 1, 3, 6, 12, and 24 h Result:Up-regulated LC3B-II and sequestosome 1 (SQSTM1) levels time- and dose-dependently. This increase was not the result of enhanced transcription, as mRNA expression of SQSTM1 and LC3B were not increased within CUR5g-exposed cells, suggesting that CUR5g might block autophagic flux rather than increase autophagosome formation.Cell Proliferation Assay Cell Line:A549 cells Concentration:0, 1, 5, 10, 20, and 40 μM Incubation Time:24 h Result:Exhibited great toxicity to A549 cells at 20 μM. Slightly decreased A549 cell number at 10 μM, while decreased the number of A549 cells significantly at 20 μM. Showed no discernable activity in healthy human umbilical vein endothelial cell (HUVEC) viability at 40?μM.
-
体内实验Animal Model:BALB/c nude mice (4-week-old, A549 cells were subcutaneously injected into the right scapula of each nude mouse)Dosage:40?mg/kg, CUR5g (40 mg/kg) and Cisplatin (1 mg/kg) Administration:Injected via caudal vein, once every 2 days for up to 15 days Result:Retarded the growth of xenografted tumors, whereas the combination treatment with Cisplatin almost completely inhibited tumor growth. Promoted the cisplatin sensitivity of A549 cells by inhibiting autophagic flux.
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体Autophagy
-
研究领域——
-
适应症——
化学信息
-
CAS Number1370032-20-4
-
分子量344.41
-
分子式C22H20N2O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 41.67 mg/mL (120.99 mM; 超声助溶 (<60°C)
-
SMILESC(\C=1C=2C(NC1)=CC=CC2)=C\3/C(=O)\C(=C\C4=CC=C(O)C=C4)\CN(C)C3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Chen J, et al. CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer. Cell Death Discov. 2022 Oct 31;8(1):435.?
产品手册
关联产品
-
SP-8356
SP-8356 是一种有效的口服活性分化簇 147 (CD147) 抑制剂,具有抗动脉粥样硬化作用。
-
Sulfisoxazole
磺胺异恶唑是一种内皮素受体拮抗剂,是一种带有恶唑取代基的磺酰胺类抗菌化合物。
-
Insecticidal agent 3...
Insecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein. Insecticidal agent 364 has antitumor activity, and by inhibiting mTOR, Insecticidal agent 364 aims to disrupt signaling pathways involved in cancer cell growth and survival, thereby potentially inhibiting tumor growth.
021-51111890
购物车()
sales@molnova.cn

